The Medicines Transparency Alliance (MeTA), launched in London in May 2008, is a multi-stakeholder alliance working to improve access and affordability of medicines for the one-third of the world’s population unable to access essential medicines due to high cost or local unavailability.
What is MeTA?
- An alliance internationally to promote dialogue and support change
- Alliances within pilot countries to focus on what can be done to increase access to quality medicines
- Support to pilot countries from the International Secretariat – funds to support country work, and, on request, technical assistance.
The organisation’s seven pilot countries include: Ghana, Jordan, Kyrgyzstan, Peru, the Philippines, Uganda and Zambia. In each country, governments have made a high-level political commitment to sign up to MeTA’s core principles, to increase accountability at all levels of the medicines supply chain, and to work with the private sector and with civil society.